<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.4 20241031//EN"
        "https://jats.nlm.nih.gov/publishing/1.4/JATS-journalpublishing1-4.dtd">
<article  article-type="research-article"        dtd-version="1.4">
            <front>

                <journal-meta>
                                    <journal-id></journal-id>
            <journal-title-group>
                                                                                    <journal-title>Dicle Medical Journal</journal-title>
            </journal-title-group>
                            <issn pub-type="ppub">1300-2945</issn>
                                        <issn pub-type="epub">1308-9889</issn>
                                                                                            <publisher>
                    <publisher-name>Dicle University</publisher-name>
                </publisher>
                    </journal-meta>
                <article-meta>
                                        <article-id pub-id-type="doi">10.5798/dicletip.1906407</article-id>
                                                                <article-categories>
                                            <subj-group  xml:lang="en">
                                                            <subject>Health Care Administration</subject>
                                                            <subject>Medical Education</subject>
                                                            <subject>Health Services and Systems (Other)</subject>
                                                    </subj-group>
                                            <subj-group  xml:lang="tr">
                                                            <subject>Sağlık Kurumları Yönetimi</subject>
                                                            <subject>Tıp Eğitimi</subject>
                                                            <subject>Sağlık Hizmetleri ve Sistemleri (Diğer)</subject>
                                                    </subj-group>
                                    </article-categories>
                                                                                                                                                        <title-group>
                                                                                                                        <article-title>The Relationship Between Blood Groups and Hidradenitis Suppurativa: A Retrospective Evaluation</article-title>
                                                                                                                                                                                                <trans-title-group xml:lang="tr">
                                    <trans-title>Kan Grupları ile Hidradenitis Suppurativa Arasındaki İlişki: Retrospektif Değerlendirme</trans-title>
                                </trans-title-group>
                                                                                                    </title-group>
            
                                                    <contrib-group content-type="authors">
                                                                        <contrib contrib-type="author">
                                                                <name>
                                    <surname>Esen</surname>
                                    <given-names>Mustafa</given-names>
                                </name>
                                                                    <aff>DICLE UNIVERSITY</aff>
                                                            </contrib>
                                                    <contrib contrib-type="author">
                                                                <name>
                                    <surname>Demirbaş</surname>
                                    <given-names>Abdullah</given-names>
                                </name>
                                                                    <aff>Kocaeli University</aff>
                                                            </contrib>
                                                    <contrib contrib-type="author">
                                                                <name>
                                    <surname>Diremsizoglu</surname>
                                    <given-names>Esin</given-names>
                                </name>
                                                                    <aff>Kocaeli University</aff>
                                                            </contrib>
                                                    <contrib contrib-type="author">
                                                                <name>
                                    <surname>Sula</surname>
                                    <given-names>Bilal</given-names>
                                </name>
                                                                    <aff>Dicle University</aff>
                                                            </contrib>
                                                                                </contrib-group>
                        
                                        <pub-date pub-type="pub" iso-8601-date="20260310">
                    <day>03</day>
                    <month>10</month>
                    <year>2026</year>
                </pub-date>
                                        <volume>53</volume>
                                        <issue>1</issue>
                                        <fpage>39</fpage>
                                        <lpage>45</lpage>
                        
                        <history>
                                    <date date-type="received" iso-8601-date="20251014">
                        <day>10</day>
                        <month>14</month>
                        <year>2025</year>
                    </date>
                                                    <date date-type="accepted" iso-8601-date="20260204">
                        <day>02</day>
                        <month>04</month>
                        <year>2026</year>
                    </date>
                            </history>
                                        <permissions>
                    <copyright-statement>Copyright © 2003, Dicle Medical Journal</copyright-statement>
                    <copyright-year>2003</copyright-year>
                    <copyright-holder>Dicle Medical Journal</copyright-holder>
                </permissions>
            
                                                                                                <abstract><p>Aims: This study aims to investigate the potential relationship between ABO blood groups and the incidence of hidradenitis suppurativa.Methods: This retrospective study included adult patients with clinically diagnosed hidradenitis suppurativa followed at a tertiary dermatology clinic (2019–2023) and healthy controls. ABO and Rh blood groups were determined using standard agglutination methods. Statistical analyses were performed using chi-square and t-testsResults: A total of 100 patients with hidradenitis suppurativa and 365 healthy controls were included in the analysis. The distribution of ABO blood groups was comparable between the two groups (p=0.650). Blood group A Rh (+) was the most common in both patients (40%) and controls (39.2%), followed by O Rh(+) (30% vs. 27. 1%). Similarly, the Rh factor distribution showed no significant difference, with 89% of patients and 89.6% of controls being Rh positive (p=1.000). When ABO and Rh blood groups were evaluated together, the overall distribution remained statistically similar across groups (p=0.958).Conclusions: This study found no significant association between ABO or Rh blood groups and the occurrence of hidradenitis suppurativa. Further studies with larger and more diverse populations are needed to confirm these findings and investigate potential underlying mechanisms.</p></abstract>
                                                                                                                                    <trans-abstract xml:lang="tr">
                            <p>Amaç: Bu çalışma, ABO kan grupları ile hidradenitis suppurativa (HS) görülme sıklığı arasındaki olası ilişkiyi araştırmayı amaçlamaktadır.Yöntemler: Bu retrospektif çalışma, 2019–2023 yılları arasında üçüncü basamak bir dermatoloji kliniğinde takip edilen, klinik olarak HS tanısı almış erişkin hastalar ile sağlıklı kontrolleri içermektedir. ABO ve Rh kan grupları standart aglütinasyon yöntemleriyle belirlenmiştir. İstatistiksel analizler ki-kare ve t-testi kullanılarak yapılmıştır.Bulgular: Analize 100 HS hastası ve 365 sağlıklı kontrol dahil edilmiştir. ABO kan grubu dağılımı iki grup arasında benzer bulunmuştur (p=0,650). Her iki grupta da en sık görülen kan grupları A Rh(+) (sırasıyla %40 ve %39,2) ve O Rh(+) (sırasıyla %30 ve %27,7) olmuştur. Rh faktörü dağılımı da benzer olup, hastaların %89’u ve kontrollerin %89,6’sı Rh pozitif bulunmuştur (p=1,000). ABO ve Rh kan grupları birlikte değerlendirildiğinde de gruplar arasında istatistiksel olarak anlamlı fark saptanmamıştır (p=0,958).Sonuç: Bu çalışma, ABO veya Rh kan grupları ile hidradenitis suppurativa gelişimi arasında anlamlı bir ilişki saptamamıştır. Ancak, bu sonuçların doğrulanması ve hastalığın olası genetik ya da immünolojik bağlantılarının ortaya konması için daha geniş kapsamlı ve çok merkezli çalışmalara ihtiyaç vardır.</p></trans-abstract>
                                                            
            
                                                            <kwd-group>
                                                    <kwd>Hidradenitis suppurativa</kwd>
                                                    <kwd>  Blood groups</kwd>
                                                    <kwd>  ABO antigens</kwd>
                                                    <kwd>  Rh antigen</kwd>
                                            </kwd-group>
                                                        
                                                                            <kwd-group xml:lang="tr">
                                                    <kwd>Hidradenitis suppurativa</kwd>
                                                    <kwd>  Kan grupları</kwd>
                                                    <kwd>  ABO antijenleri</kwd>
                                                    <kwd>  Rh antijeni.</kwd>
                                            </kwd-group>
                                                                                                            </article-meta>
    </front>
    <back>
                            <ref-list>
                                    <ref id="ref1">
                        <label>1</label>
                        <mixed-citation publication-type="journal">1.Zouboulis CC, Desai N, Emtestam L, et al. EuropeanS1 guideline for the treatment of hidradenitissuppurativa/acne inversa. JEADV. 2015;29(4):619–44.</mixed-citation>
                    </ref>
                                    <ref id="ref2">
                        <label>2</label>
                        <mixed-citation publication-type="journal">2.Moltrasio C, Tricarico PM, Romagnuolo M, MarzanoAV, Crovella S. Hidradenitis Suppurativa: A Perspectiveon Genetic Factors Involved in the Disease.Biomedicines. 2022;10(8):2039.</mixed-citation>
                    </ref>
                                    <ref id="ref3">
                        <label>3</label>
                        <mixed-citation publication-type="journal">3.Esen M, Demirbas A, Diremsizoglu E. Is Prenatal SexHormone Balance a Risk Factor for the Development ofHidradenitis Suppurativa? Selcuk Med J 2025;41(4):211-216.</mixed-citation>
                    </ref>
                                    <ref id="ref4">
                        <label>4</label>
                        <mixed-citation publication-type="journal">4.Hosoi E. Biological and clinical aspects of ABO bloodgroup system. J Med Investig JMI. 2008;55(3–4):174–82.</mixed-citation>
                    </ref>
                                    <ref id="ref5">
                        <label>5</label>
                        <mixed-citation publication-type="journal">5. Felsenfeld A, Peterson J, Schloss J, Guyer M. Assessingthe quality of the DNA sequence from the HumanGenome Project. Genome Res. 1999;9(1):1–4.</mixed-citation>
                    </ref>
                                    <ref id="ref6">
                        <label>6</label>
                        <mixed-citation publication-type="journal">6.Garratty G. Blood groups and disease: a historicalperspective. Transfus Med Rev. 2000;14(4):291–301.</mixed-citation>
                    </ref>
                                    <ref id="ref7">
                        <label>7</label>
                        <mixed-citation publication-type="journal">7.Scala E, Cacciapuoti S, Garzorz-Stark N, et al.Hidradenitis Suppurativa: Where We Are and WhereWe Are Going. Cells. 2021;10(8):2094.</mixed-citation>
                    </ref>
                                    <ref id="ref8">
                        <label>8</label>
                        <mixed-citation publication-type="journal">8.Reid ME, Lomas-Francis C, Olsson ML. The BloodGroup Antigen FactsBook.3rd ed. Elsevier. 2012;745p.</mixed-citation>
                    </ref>
                                    <ref id="ref9">
                        <label>9</label>
                        <mixed-citation publication-type="journal">9.Kiechl S, Paré G, Barbalic M, et al. Association ofvariation at the ABO locus with circulating levels ofsoluble intercellular adhesion molecule-1, soluble P-selectin, and soluble E-selectin: a meta-analysis. CircCardiovasc Genet. 2011;4(6):681-686.</mixed-citation>
                    </ref>
                                    <ref id="ref10">
                        <label>10</label>
                        <mixed-citation publication-type="journal">10.Del Duca E, Morelli P, Bennardo L, Di Raimondo C,Nisticò SP. Cytokine Pathways and InvestigationalTarget Therapies in Hidradenitis Suppurativa. Int J MolSci. 2020;21(22):8436.</mixed-citation>
                    </ref>
                                    <ref id="ref11">
                        <label>11</label>
                        <mixed-citation publication-type="journal">11.Terzi E, Türsen B, Dursun P, et al. The Relationshipbetween ABO Blood Groups and Acne Vulgaris. Saudi JMed Med Sci. 2016;4(1):26–8.</mixed-citation>
                    </ref>
                                    <ref id="ref12">
                        <label>12</label>
                        <mixed-citation publication-type="journal">12.Gürok NG. The correlation between ABO bloodtypes and acne vulgaris severity. J Cosmet Dermatol.2023;22(8):2318–23.</mixed-citation>
                    </ref>
                                    <ref id="ref13">
                        <label>13</label>
                        <mixed-citation publication-type="journal">13.Çildağ S, Kara Y, Şentürk T. ABO blood groups andrheumatic diseases. Eur J Rheumatol. 2017;4(4):250–3.</mixed-citation>
                    </ref>
                                    <ref id="ref14">
                        <label>14</label>
                        <mixed-citation publication-type="journal">14.Türsen B, Terzi E, Bulut B, Türsen Ü, Erdem T. TheRelationship Between ABO Blood Groups and PsoriasisVulgaris. J Turk Acad Dermatol 2015; 9(1): 1591a1.</mixed-citation>
                    </ref>
                                    <ref id="ref15">
                        <label>15</label>
                        <mixed-citation publication-type="journal">15.Dadras MS, Golfeshan A, Younespour S. ABO bloodgroup antigens in patients with psoriasis andpemphigus vulgaris. 2015;18(1).</mixed-citation>
                    </ref>
                                    <ref id="ref16">
                        <label>16</label>
                        <mixed-citation publication-type="journal">16.Valikhani M, Kavand S, Toosi S, Kavand G, Ghiasi M.ABO blood groups, rhesus factor and pemphigus.Indian J Dermatol. 2007;52(4):176.</mixed-citation>
                    </ref>
                                    <ref id="ref17">
                        <label>17</label>
                        <mixed-citation publication-type="journal">17. Valikhani M, Vosooghian L. Association of ABO &amp; Rhblood groups with Vitiligo. Iran J Dermatol.2001;4(2):13–6.</mixed-citation>
                    </ref>
                                    <ref id="ref18">
                        <label>18</label>
                        <mixed-citation publication-type="journal">18.Altunisik N, Turkmen D, Kayhan Tetik B, Sener S.Evaluation of the relationship between androgeneticalopecia and blood groups and Rhesus factor. Int J ClinPract. 2021;75(1):e13647.</mixed-citation>
                    </ref>
                                    <ref id="ref19">
                        <label>19</label>
                        <mixed-citation publication-type="journal">19.İslamoğlu ZGK, Unal M. Is there an association ofABO blood groups and Rhesus factor with alopeciaareata? J Cosmet Dermatol. 2018;17(6):1271–4.</mixed-citation>
                    </ref>
                                    <ref id="ref20">
                        <label>20</label>
                        <mixed-citation publication-type="journal">20.Dahalan NH, Tuan Din SA, Mohamad SMB.Association of ABO blood groups with allergic diseases:a scoping review. BMJ Open. 2020;10(2):e029559.</mixed-citation>
                    </ref>
                                    <ref id="ref21">
                        <label>21</label>
                        <mixed-citation publication-type="journal">21.Gangopadhyay DN, Naskar B, Roy AK. Atopicdermatitis and ABO blood group. Indian J Dermatol.2006;51(1):33.</mixed-citation>
                    </ref>
                                    <ref id="ref22">
                        <label>22</label>
                        <mixed-citation publication-type="journal">22.Kjær C, Larsen LK, Sondrup MA, et al. ABO BloodTypes in Atopic Dermatitis: A Danish Survey. Clin ExpDermatol Ther. 2018; 2018(1):CEDT-144.</mixed-citation>
                    </ref>
                                    <ref id="ref23">
                        <label>23</label>
                        <mixed-citation publication-type="journal">23.Kumar T, Laller S, Malik M, Puri G. Association ofABO blood grouping with oral lichen planus. UniversRes J Dent. 2014;4:93.</mixed-citation>
                    </ref>
                                    <ref id="ref24">
                        <label>24</label>
                        <mixed-citation publication-type="journal">24.Ozturk M, An I. Do blood groups play a role inetiology of rosacea? J Cosmet Dermatol.2020;19(2):400–3.</mixed-citation>
                    </ref>
                                    <ref id="ref25">
                        <label>25</label>
                        <mixed-citation publication-type="journal">25.Shahidi-Dadras M, Sadeghzade-Bazargan A, AzizianZ, Hassani P, Golfeshan A. Evaluation of the AssociationBetween ABO Blood Groups and Lichen Planus. J SkinStem Cell.2016;3(3).</mixed-citation>
                    </ref>
                                    <ref id="ref26">
                        <label>26</label>
                        <mixed-citation publication-type="journal">26.Tamega A de A, Bezerra LVG da SP, Pereira F de P,Miot HA. Blood groups and discoid lupuserythematosus. An Bras Dermatol. 2009;84(5):477–81.</mixed-citation>
                    </ref>
                            </ref-list>
                    </back>
    </article>
